Replies to post #786493 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

It's taken NW so long to get commercialization even started, just in the UK alone. Without actually demonstrating sales growth, they don't have a huge amount of negotiating leverage. All the 'only shorts manipulating the pps' is stopping NW from having a ginormous market cap has long since been proven way too optimistic. Some people don't know how to smell the coffee, but the dreams of stuff like stealth application to the FDA and the like are just that, silly dreams of the less than serious. NW might build up to much wider recognition and credibility, but they have a lot of work to do to get to a market cap of many billions of $. Anyway, I don't have time to get into extended arguments with either permabears or obsessive longs, so I'll leave this argument now. GLTA.

You are wise to leave off.

Telling the truth here will make you very unpopular, fast, and they’ll say they’re serving you Cab in the mythical boiler room.

I suggest you allow the calendar to win your arguments.

Folks can politicize a calendar and resist accepting it as happened with the present Gregorian calendar, but ultimately there’s no defending 5 years from when data lock was expected.

There is no foreseeable near-term result management can possibly produce at this point that will justify all these years (and lost lives) and especially the extra years and lives since September 2020 when the game changing news should have landed with full impact and been amplified by NWBO in mainstream and social media by the company. They knew how to get on Fox Business with far less in hand to garner airtime back in 2013 so there are no excuses.

Many people probably regret having seen that segment. I know I do.

I’ll decide shortly but it might be time to tag team with the calendar, leave the discussion and let the calendar win some more arguments.